|| Checking for direct PDF access through Ovid
To evaluate whether the −174 G/C promoter polymorphism of the interleukin-6 gene, gender, the monocyte density of the endotoxin receptor CD14, or the inflammatory cytokines tumor necrosis factor-α or interleukin-1β influence the interleukin-6 response of whole blood to endotoxin.Analysis of interleukin-6 release from endotoxin-stimulated human whole blood.Medical research laboratory.Healthy human blood donors.None.The interleukin-6 −174 G/C and the tumor necrosis factor −308 G/A promoter polymorphisms were determined by real-time polymerase chain reaction assay by using specific fluorescence labeled hybridization probes. Monocyte CD14 expression was assessed by flow cytometry. After incubation of whole blood with endotoxin, plasma concentrations of interleukin-6, tumor necrosis factor-α, and interleukin-1β were measured by means of chemiluminescence. The interleukin-6 concentrations were lower (p = .005) in individuals who were CG heterozygotes compared with individuals homozygous for the C or the G. The difference between C and G homozygotes was not significant (p = .67). The interleukin-6 response was enhanced in men compared with women (p = .015). There was no correlation between interleukin-6 concentrations and monocyte CD14 density. Interleukin-6 concentrations correlated with the concentrations of tumor necrosis factor-α (r = .59, p = .01) and interleukin-1β (r = .47, p = .01). There was no linkage between the tumor necrosis factor −308 and the interleukin-6 −174 polymorphisms.The interleukin-6 response to endotoxin was influenced by gender and correlated with the concentrations of more proximal cytokine tumor necrosis factor-α and interleukin-1β. The interleukin-6 −174 G/C promoter polymorphism can only partly predict the interleukin-6 response of human whole blood to endotoxin stimulation, and the results were different from previous reporter gene assays that reported higher interleukin-6 concentrations for the G allele. Tumor necrosis factor −308 G homozygotes produce the lowest tumor necrosis factor concentrations. The number of tumor necrosis factor −308 G homozygotes was not higher among interleukin-6 −174 heterozygotes, and thus this cannot account for their significantly smaller interleukin-6 production.